ChemGenex Pharmaceuticals Inc., Vernalis deal

CXS received a AUS$720,000 (US$568,000) milestone payment from VER under their 2004 depression target discovery deal (see BioCentury, Sept. 20, 2004). The companies did not disclose what triggered the...